NYSE:RVTY
Revvity (RVTY)
Financials 
Technical Analysis 
Jul 4, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
Revvity, traded under the symbol RVTY-N, is a significant player in the life sciences industry. After a period of stagnation, the company demonstrated promising growth last October, leading to an optimistic revision of its full-year earnings forecast. The stock is currently priced at a price-to-earnings (PE) ratio of 21, which is notably the most affordable in its sector, suggesting potential upside for investors. This performance has garnered attention from market analysts, indicating that Revvity may be on the verge of a substantial turnaround. Overall, the positive outlook and competitive valuation position Revvity as an intriguing option in the life sciences field.
- «
- ‹
- 1
- ›
- »
Popular Articles
Most Recent Experts
Revvity (RVTY) Frequently Asked Questions
What is Revvity stock symbol?
Revvity is a American stock, trading under the symbol RVTY (previously RVTY-N on Stockchase) on the New York Stock Exchange (RVTY). It is usually referred to as NYSE:RVTY or RVTY
Is Revvity a buy or a sell?
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on RVTY (previously RVTY-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Revvity.
Is Revvity a good investment or a top pick?
Revvity was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Revvity.
Why is Revvity stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Revvity.
Is Revvity worth watching?
Revvity is covered by Stockchase experts and is worth watching.
What is Revvity stock price?
On 2026-07-02, Revvity (RVTY) stock closed at a price of $113.72.
A life sciences company. After years of going nowhere, they finally posted good numbers last October and raised their full-year earnings forecast. Trades at 21x PE, the cheapest in the sector.